marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 02-29-2024
DermTech Balance Sheet 2011-2024 | DMTK
Annual Balance Sheet DermTech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-33.6 M | -76.1 M | -175 M | -23.9 M | -30.5 K | -450 K | -25 K | -16.4 K | - | - | - | - | - |
Long Term Debt |
38 K | 53 K | 136 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.07 M | 1.63 M | 1.45 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 865 K | 5.03 M | 5.03 M | - | - | - | - | - | - | - |
Total Current Liabilities |
13.4 M | 15.6 M | 12.2 M | 5.42 M | 5.72 M | 41.9 K | - | - | - | - | - | - | - |
Total Liabilities |
64.8 M | 69.7 M | 18.6 M | 6.29 M | 6.59 M | 5.07 M | 173 K | 128 K | - | - | - | - | - |
Deferred Revenue |
196 K | 109 K | 1.38 M | 905 K | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-424 M | -323 M | -206 M | -126 M | 1.8 M | 854 K | -2.79 K | -2.73 K | - | - | - | - | - |
Total Assets |
122 M | 202 M | 248 M | 69.8 M | 12.4 M | 147 M | 195 K | 150 K | - | - | - | - | - |
Cash and Cash Equivalents |
36.7 M | 77.8 M | 177 M | 24.2 M | 15.4 M | 4.75 M | 25 K | - | - | - | - | - | - |
Book Value |
57.2 M | 132 M | 230 M | 63.5 M | 5.85 M | 142 M | 22.2 K | 22.3 K | - | - | - | - | - |
Total Shareholders Equity |
57.2 M | 132 M | 230 M | 61.8 M | 12.5 M | -5.36 M | 22.2 K | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet DermTech
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
42 K | 46 K | 49 K | 53 K | 77 K | 111 K | 105 K | 136 K | 216 K | 170 K | 198 K | 226 K | 226 K | 226 K | 226 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
64.8 M | 69 M | 69.9 M | 69.7 M | 39.1 M | 37.5 M | 36 M | 18.6 M | 18 M | 8.39 M | 8.2 M | 7.94 M | 7.94 M | 7.94 M | 7.94 M | 6.35 M | 5.72 M | 5.72 M | 5.72 M | 11 M | 11 M | 5.14 M | 5.07 M | 5.07 M | 5.06 M | 5.09 M | 173 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
236 K | 295 K | 242 K | 109 K | 417 K | 1.31 M | 1.35 M | 1.38 M | 1.36 M | 1.37 M | 1.36 M | 905 K | 905 K | 905 K | 905 K | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 1.55 M | 1.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-405 M | -386 M | -354 M | -323 M | -295 M | -266 M | -236 M | -206 M | -180 M | -160 M | -143 M | -128 M | -128 M | -128 M | -128 M | -91.6 M | -91.1 M | -91.1 M | -91.1 M | -71.4 M | -71.4 M | 1.3 M | 854 K | 464 K | 212 K | -34.5 K | -2.79 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
138 M | 157 M | 177 M | 202 M | 194 M | 216 M | 240 M | 248 M | 270 M | 276 M | 265 M | 69.8 M | 69.8 M | 69.8 M | 69.8 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 5.66 M | 5.66 M | 147 M | 147 M | 146 M | 146 M | 146 M | 195 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
37.2 M | 42.8 M | 48.4 M | 77.8 M | 95.5 M | 120 M | 145 M | 177 M | 204 M | 230 M | 219 M | 24.2 M | 24.2 M | 24.2 M | 24.2 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 4.75 M | 4.75 M | 386 K | 450 K | 554 K | 607 K | 745 K | 607 K | - | - | 14.7 K | 16.4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
73.1 M | 88.1 M | 107 M | 132 M | 155 M | 179 M | 203 M | 230 M | 252 M | 267 M | 257 M | 61.8 M | 61.8 M | 61.8 M | 61.8 M | 11.9 M | 12.5 M | 12.5 M | 12.5 M | -5.36 M | -5.36 M | 142 M | 142 M | 141 M | 141 M | 141 M | 22.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
73.1 M | 88.1 M | 107 M | 132 M | 155 M | 179 M | 203 M | 230 M | 252 M | 267 M | 257 M | 61.8 M | 61.8 M | 61.8 M | 61.8 M | 11.9 M | 12.5 M | 12.5 M | 12.5 M | -5.36 M | -5.36 M | 5 M | 1.46 M | -805 K | 5 M | 5 M | 22.2 K | - | - | - | 22.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency